Tacere Therapeutics, Inc. specializes in the development of novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). Combining expertise in RNA interference (RNAi), gene medicine, and novel biologicals, Tacere possesses proprietary skill in the identification and development of RNAi therapeutics.
Company Details
- Employees
- 3
- Address
- 220 Montgomery St, San Francisco,california 94104,united States
- Phone
- (408)960-2205
- in****@****bio.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- tacerebio.com
- Keywords
- in RNA interference (RNAi).
- HQ
- San Francisco, California
Tacere Therapeutics Questions
Tacere Therapeutics's helpline number is (408)960-2205
Tacere Therapeutics's website is tacerebio.com
Tacere Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tacere-therapeutics
Tacere Therapeutics has
3 employees.
View email and phone details for 3
employees at Tacere Therapeutics.
Tacere Therapeutics's industry is
Pharmaceutical Manufacturing
Tacere Therapeutics's top competitors are
Sangamo Therapeutics, Inc.,
Dna2.0 (Now Atum),
Rna Nanobiotics, Inc.,
Ambys Medicines,
Genedit,
Rna Therapeutics,
Benitec Biopharma Inc.,
Rna Therapeutics Inc,
Genoval Therapeutics,
Ribobio.
Tacere Therapeutics's support email address is info@tacerebio.com
Tacere Therapeutics's categories are Pharmaceutical Manufacturing
